#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15468	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2068	741.4	0	.	n	.	0	A69G	SNP	69	69	A	271	271	G	866	G,A,T	347,451,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15468	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2068	741.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1652	1652	T	843	T,C	776,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15468	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2068	741.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1386	1386	C	962	C,T	900,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	15468	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2068	741.4	0	HET	.	.	.	C223T	.	223	223	C	425	425	C	856	C,T	626,171	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28422	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3749	756.5	0	.	n	.	0	C1176T	SNP	1176	1176	C	1533	1533	T	878	T	825	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28422	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3749	756.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1694	1694	A	900	A,G	840,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28422	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3749	756.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2328	2328	C	955	C	871	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28422	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3749	756.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2402	2402	A	907	A	848	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	28422	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3749	756.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2954	2954	C	920	C	867	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2202	folP	852	852	99.88	folP.l6.c4.ctg.1	1463	149.8	0	.	p	.	0	E151K	NONSYN	451	453	GAA	755	757	AAA	207;211;208	A;A;A	197;201;198	.	.
folP.WHO_Z_01426c	folP.WHO_Z_01426c	1	1	539	2202	folP	852	852	99.88	folP.l6.c4.ctg.1	1463	149.8	1	SNP	p	R228S	1	.	.	682	684	AGC	986	988	AGC	241;243;246	A;G;C	227;230;232	folP.WHO_Z_01426c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	6044	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3399	177.1	0	.	p	.	0	K261del	DEL	781	781	A	1107	1107	A	197	A	186	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	6044	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3399	177.1	1	SNP	p	S91F	0	.	.	271	273	TCC	597	599	TCC	194;196;199	T;C;C	182;186;185	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	6044	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3399	177.1	1	SNP	p	D95N	0	.	.	283	285	GAC	609	611	GAC	202;200;200	G;A;C	188;181;182	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	6044	gyrA	2751	2751	99.89	gyrA.l15.c4.ctg.1	3399	177.1	1	SNP	p	D95G	0	.	.	283	285	GAC	609	611	GAC	202;200;200	G;A;C	188;181;182	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	1814	mtrR	633	633	100.0	mtrR.l15.c17.ctg.1	1270	142.4	1	SNP	p	G45D	0	.	.	133	135	GGC	432	434	GGC	230;237;235	G;G;C	213;220;218	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	912	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	962	94.1	0	.	n	.	0	A197.	DEL	197	197	A	564	564	A	217	A	202	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5514	parC	2304	2304	99.91	parC.l6.c30.ctg.1	2847	192.8	1	SNP	p	D86N	0	.	.	256	258	GAC	538	540	GAC	200;200;206	G;A;C	189;188;193	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5514	parC	2304	2304	99.91	parC.l6.c30.ctg.1	2847	192.8	1	SNP	p	S87I	0	.	.	259	261	AGT	541	543	AGT	209;210;211	A;G;T	196;196;197	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5514	parC	2304	2304	99.91	parC.l6.c30.ctg.1	2847	192.8	1	SNP	p	S87R	0	.	.	259	261	AGT	541	543	AGT	209;210;211	A;G;T	196;196;197	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5514	parC	2304	2304	99.91	parC.l6.c30.ctg.1	2847	192.8	1	SNP	p	S87W	0	.	.	259	261	AGT	541	543	AGT	209;210;211	A;G;T	196;196;197	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5514	parC	2304	2304	99.91	parC.l6.c30.ctg.1	2847	192.8	1	SNP	p	S88P	0	.	.	262	264	TCC	544	546	TCC	208;206;204	T;C;C,T,A	191;188;188,1,1	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4612	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2636	174.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1595	1597	GGC	225;225;224	G;G;C	207;206;204	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2289	178.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1246	1248	GCA	222;226;227	G;C;A	197;202;208	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2289	178.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1249	1251	ATC	227;229;231	A;T;C	208;209;207	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2289	178.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1261	1263	GTG	225;227;229	G;T;G	206;207;206	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2289	178.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1261	1263	GTG	225;227;229	G;T;G	206;207;206	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2289	178.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1765	1767	ACC	204;207;211	A;C;C	176;190;196	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2289	178.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1819	1821	GCG	181;180;178	G;C;G	161;143;144	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2289	178.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1819	1821	GCG	181;180;178	G;C;G	161;143;144	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2289	178.4	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1942	1944	GGC	170;166;164	G;G;C	155;155;150	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2289	178.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1951	1953	GGC	166;162;162	G;G;C	158;153;151	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4106	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2289	178.4	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1969	1971	CTG	143;146;148	C,G;T;G	108,2;106;118	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6200	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3090	200.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1660	1662	CCG	217;216;216	C;C;G	191;202;193	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2266	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1627	138.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	468	468	C	170	C	155	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2954	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	207.7	0	.	p	.	0	N38E	NONSYN	112	114	AAT	334	336	GAA	247;245;243	G;A;A	232;230;227	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2954	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	207.7	0	.	p	.	0	N134D	NONSYN	400	402	AAT	622	624	GAT	223;224;228	G;A;T	214;217;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2954	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	207.7	0	.	p	.	0	P175S	NONSYN	523	525	CCA	745	747	TCA	231;232;231	T;C;A	213;212;210	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2954	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	207.7	0	.	p	.	0	D212N	NONSYN	634	636	GAT	856	858	AAT	228;232;230	A;A;T	223;224;218	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2954	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	207.7	0	.	p	.	0	A218V	NONSYN	652	654	GCC	874	876	GTC	224;223;224	G;T;C	218;220;221	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2954	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	207.7	0	.	p	.	0	F222S	NONSYN	664	666	TTT	886	888	TCT	231;235;238	T;C;T,A	223;228;226,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2954	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	207.7	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1204	1206	GCA	259;264;264	G;C;A	239;242;244	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2954	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	207.7	1	SNP	p	G120K	1	.	.	358	360	AAG	580	582	AAG	239;236;236	A;A,G;G	220;216,1;217	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2954	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	207.7	1	SNP	p	A121D	1	.	.	361	363	GAC	583	585	GAC	237;238;238	G;A;C	219;221;222	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2954	porB1b	1047	1047	99.14	porB1b.l15.c17.ctg.1	1411	207.7	1	SNP	p	D121N	0	.	.	361	363	GAC	583	585	GAC	237;238;238	G;A;C	219;221;222	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11288	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4820	233.6	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2020	2022	AAT	271;272;273	A;A;TAAA,TAA	250;254;257,1	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1212	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	924	129.8	1	SNP	p	V57M	1	.	.	169	171	ATG	465	467	ATG	255;257;258	A;T,C;G	236;237,1;239	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
